| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01f7d3d9295f6bf513bd55ec626cf461 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-155 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 |
| filingDate |
2018-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b17f57a009ec964a11d8b22105679f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1342c68ac42f2a9fc7b8a29338f0275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46302fed404571b065acd9cb33c8f6d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d5ea39e6f55f78b44c30f4343a121a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e53673f73b9d686eacdbe98461cae5cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c46779ec7c43dd006de517b5c6828060
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a90ff37cc355e82a55cb801e94b26ba5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0a8e2758b65dea7d816798c633a4c2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f40c910165e583409bdb07a862f0d58 |
| publicationDate |
2020-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-111295381-A |
| titleOfInvention |
Intermediates that can be used to synthesize selective inhibitors against protein kinases and methods for their preparation |
| abstract |
The present invention provides intermediates that can be used for synthesizing aminopyrimidine derivatives or pharmaceutically acceptable salts thereof with selective inhibitory activity on protein kinases, especially on mutant epidermal growth factor receptor protein kinases; and preparation methods thereof. Furthermore, the present invention provides novel intermediates that can be used to prepare one or more of the described methods. |
| priorityDate |
2017-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |